Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Hypertension. 2013 Mar 4;61(5):1103–1110. doi: 10.1161/HYPERTENSIONAHA.111.00226

Figure 2. Fetal weight, fetal resorptions, placental efficiency and heart weight.

Figure 2

Fetal weight (Panel A) was decreased in reduced utero-placental perfusion pressure (RUPP) compared to normal pregnant (NP). Pravastatin administration resulted in fetuses that were not smaller than fetuses from NP dams or from NP dams treated with pravastatin. There were an increased number of fetal resorptions in the RUPP compared to the NP rats and pravastatin had no effect in either group (Panel B). Placental efficiency was decreased by RUPP and this was ameliorated by pravastatin (Panel C). Heart weight was increased by RUPP and this was ameliorated by pravastatin (Panel D). Data are expressed as mean ± SEM, * indicates p<0.05.